Examining the safety, feasibility and efficacy of an exercise-training program in patients awaiting a liver transplantation: a randomised controlled trial.

Mr Matthew Wallen0 个研究点目标入组 21 人开始时间: 2014年7月25日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Candidate for Liver Transplant - as per guidelines proposed by the Transplant Society of Australia and New Zealand for Organ Transplant from Decreased Donors
•- Gender - males and females are eligible. The study will endeavor to recruit approximately equal numbers of males and females.
•- Age - Individuals aged 18 to 69 years old are eligible. At the Princess Alexandra Hospital, patients are not eligible for a liver transplant following the age of 69 years old due to organ allocation policies.
•- Ethnicity - All ethnic groups are eligible for the study. There is likely to be incidental recruitment of participants of Aboriginal or Torres Strait Islander ethnicity.
•- Willingness to participate - patients must be willing to be randomized to either the exercise intervention or usual care groups and to adhere to the protocol that they have been assigned.

•- Patients that have previously undergone a liver transplant
•- On transplant listing for other organs
•- Currently smoking
•- Any abnormality during the cardiopulmonary exercise test that indicates that it would be considered unsafe to participate in an exercise training intervention
•- Uncontrolled diabetes mellitus
•- Orthopaedic and/or neurological limitation to exercise as assessed by the principal investigator

发起方

Mr Matthew Wallen